先端医科学研究所

Medicine & Life Sciences

1. Adenocarcinoma 8%
2. Adenocarcinoma of Lung 10%
3. Anaphase-Promoting Complex-Cyclosome 10%
4. Antibodies 17%
5. Antigens 30%
6. Apoptosis 10%
7. Astrocytes 10%
8. Autoantibodies 12%
9. B-Lymphocytes 9%
10. Biomarkers 8%
11. Brain 19%
12. Brain Neoplasms 16%
13. Breast Neoplasms 14%
14. Cadherins 11%
15. Cancer Vaccines 10%
16. Carcinogenesis 19%
17. Catenins 9%
18. Cell Cycle 9%
19. Cell Line 27%
20. Cell Movement 11%
21. Cell Proliferation 10%
22. Cell Survival 9%
23. Cholangiocarcinoma 17%
24. Cisplatin 9%
25. Clone Cells 9%
26. Colonic Neoplasms 10%
27. Colorectal Neoplasms 10%
28. Complementary DNA 10%
29. Cytokines 8%
30. Cytotoxic T-Lymphocytes 16%
31. Dendritic Cells 24%
32. DNA Damage 8%
33. Down-Regulation 15%
34. Epithelial Cell Adhesion Molecule 10%
35. Epithelial Cells 11%
36. Epithelial-Mesenchymal Transition 21%
37. Epitopes 24%
38. Fibroblasts 12%
39. Forensic Anthropology 12%
40. Gene Expression 11%
41. Genes 26%
42. Glioblastoma 29%
43. Glioma 62%
44. gp100 Melanoma Antigen 11%
45. Graft vs Host Disease 21%
46. Growth 19%
47. Heterografts 9%
48. HLA Antigens 9%
49. HLA-A2 Antigen 23%
50. HLA-A24 Antigen 13%
51. Idiopathic Thrombocytopenic Purpura 14%
52. Immunosuppressive Agents 11%
53. Immunotherapy 52%
54. In Vitro Techniques 16%
55. Induced Pluripotent Stem Cells 11%
56. Interleukin-2 15%
57. Lacrimal Apparatus 15%
58. Macrophages 8%
59. MART-1 Antigen 9%
60. Melanocytes 15%
61. Melanoma 71%
62. Melanoma-Specific Antigens 55%
63. Messenger RNA 9%
64. Mutation 13%
65. Neoplasm Antigens 42%
66. Neoplasm Metastasis 23%
67. Neoplasms 100%
68. Neoplastic Stem Cells 71%
69. Neural Stem Cells 17%
70. Neurons 13%
71. Oligodendroglia 8%
72. Optogenetics 18%
73. Oryzias 8%
74. Osteosarcoma 21%
75. Oxidation-Reduction 10%
76. Oxidative Stress 9%
77. Peptides 22%
78. Phenotype 17%
79. Phosphorylation 8%
80. Phosphotransferases 9%
81. Population 8%
82. Protein Isoforms 10%
83. Proteins 19%
84. Reactive Oxygen Species 11%
85. Serum 10%
86. Stem Cells 38%
87. Stomach 12%
88. Stomach Neoplasms 15%
89. Sulfasalazine 21%
90. Survival 10%
91. Systemic Scleroderma 9%
92. T-Lymphocyte Epitopes 12%
93. T-Lymphocytes 63%
94. Therapeutics 23%
95. Transgenic Mice 10%
96. Tumor Microenvironment 14%
97. Tumor Necrosis Factor-alpha 10%
98. Tumor-Infiltrating Lymphocytes 44%
99. Up-Regulation 8%
100. Vaccination 11%